Preparation method and application of Aci2 gene deleted zebrafish mutant

The use of CRISPR/Cas9 technology to prepare Ace2 gene deletion mutants in zebrafish has solved the problem of the lack of effective models in existing technologies, enabled in-depth research on the regulatory mechanism of Ace2 in fish growth and development, and promoted genetic improvement in aquaculture.

CN119040360APending Publication Date: 2024-11-29SOUTHERN MARINE SCI & ENG GUANGDONG LAB (ZHUHAI) +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411155773.7
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-22
Publication Date
2024-11-29

AI Technical Summary

Technical Problem

The lack of effective research models for the function of the zebrafish Ace2 gene in existing technologies limits our understanding of the role and regulatory mechanism of Ace2 in fish growth and development, and affects the progress of genetic improvement in aquaculture.

Method used

CRISPR/Cas9 technology was used to design sgRNA targeting exon 1 of the zebrafish ace2 genome. The mixture of sgRNA and Cas9 protein was injected into zebrafish fertilized eggs via microinjection to prepare Ace2 gene deletion zebrafish mutants. Genotyping and screening were then performed to obtain homozygous mutants.

Benefits of technology

A simple, low-cost, short-cycle, and reliable Ace2 gene-deficient zebrafish mutant model was constructed, which can significantly reflect the mechanism by which Ace2 regulates intestinal function and growth and development, reduce experimental costs, and conduct in-depth research on the regulatory mechanism of Ace2 in fish growth, providing a theoretical basis for aquaculture.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119040360A_ABST
    Figure CN119040360A_ABST
Patent Text Reader

Abstract

The invention discloses a preparation method of an Ace2 gene-deleted zebrafish mutant, which comprises the following steps: mixing sgRNA fragments synthesized by artificial in-vitro transcription and Cas9 protein, injecting the mixed solution into zebrafish fertilized eggs in 1-2 cell stages through micro-injection, incubating the fertilized eggs, and culturing to obtain the Ace2 gene-deleted zebrafish mutant. The invention also provides application of the Ace2 gene deleted zebrafish mutant obtained according to the method to research ace2 regulation and control of intestinal function mediated fish growth mechanism, research of host genetic mediated intestinal function and intestinal flora regulation and control mechanism, and screening of drugs and treatment methods for treating intestinal disorder. And screening the intestinal flora beneficial to the homeostasis and growth of the intestinal tract. The growth inhibition model constructed by the method disclosed by the invention has a remarkable effect, can effectively reflect the generation mechanism that ace2 regulates the intestinal function so as to influence growth and development, and is low in cost, short in period, good in repeatability and high in reliability.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the field of biological genetic engineering, and specifically relates to a preparation method and application of an Ace2 gene-deficient zebrafish mutant. Background Art

[0002] With the rapid development of molecular biology and genetic engineering technology, gene editing technology, especially the CRISPR-Cas9 system, has become an important tool in current biological science research. This technology has been widely used in many biological fields due to its high efficiency, precision and ease of operation, including the construction of disease models, the study of gene function, and the treatment of genetic diseases. As a classic model organism, zebrafish (Danio rerio) is widely used in biomedical research due to its unique biological characteristics, such as transparent embryos, rapid growth cycles and highly conserved gene sequences with humans. Especially in the fields of growth and development, genetic diseases and drug screening, the zebrafish model provides us with a window to deeply understand gene functions and disease mechanisms.

[0003] As a key physiological regulator, ACE2 (angiotensin-converting enzyme 2) has shown its important role in the study of human cardiovascular and metabolic diseases in recent years. Although the function of ACE2 in mammalian physiological processes has been studied and understood to a certain extent, the role and regulatory mechanism of the Ace2 gene in growth and development in non-mammalian models, especially in model organisms such as zebrafish, is still not clear enough.

[0004] In addition, with the rapid development of the global aquaculture industry, how to improve the growth rate of farmed fish and enhance their disease resistance and adaptability through genetic improvement and biotechnology has become a research hotspot. However, the lack of an effective gene function research model has limited the progress of scientific research and application in this field.

[0005] Therefore, developing a zebrafish ace2 gene mutation model based on gene editing technology to study the role of the ace2 gene in fish growth and development can not only provide a new scientific basis for understanding the growth mechanism of zebrafish and even a wide range of fish, but also provide technical support for genetic improvement in aquaculture, which has important theoretical value and application prospects. Summary of the invention

[0006] The purpose of the present invention is to provide a method for preparing an Ace2 gene-deficient zebrafish mutant with simple operation and obvious effect in view of the above technical problems to be solved.

[0007] In order to achieve the above invention objectives, the present invention provides a method for preparing an Ace2 gene-deficient zebrafish mutant, which comprises the following steps: mixing an artificial in vitro transcribed sgRNA fragment and a Cas9 protein, injecting the mixture into a zebrafish fertilized egg at the 1-2 cell stage by microinjection, and culturing the fertilized egg after hatching to obtain the Ace2 gene-deficient zebrafish mutant.

[0008] Preferably, sgRNA is designed for exon 1 of the zebrafish ace2 genome using CRISPR / Cas9 technology.

[0009] More preferably, the sgRNA target sequence is located on exon 1 of the zebrafish ace2 genome, and the sgRNA target sequence is shown as 5'-GGCCTGCTGTCAGACTGTGG-3'.

[0010] More preferably, the PCR primer pair for sgRNA is as follows:

[0011] Upstream forward primer sequence: 5′-CAACAGCGTCAGAATCGGTG-3′;

[0012] Downstream reverse primer sequence: 5′-GTTGAGGAATTCCCTTGCTCTG-3′.

[0013] Preferably, the vector used to express sgRNA is a pDR274-sgRNA vector.

[0014] Preferably, the specific steps of the method are as follows:

[0015] S1, the gRNA target sequence was designed on exon 1 of the zebrafish ace2 genome, and the sgRNA target sequence was 5'-GGCCTGCTGTCAGACTGTGG-3';

[0016] S2, synthetic primers:

[0017] sgRNA synthesis upstream forward primer: 5′-TAGGCCTGCTGTCAGACTGTGG-3′;

[0018] sgRNA synthesis downstream reverse primer: 5′-AAACCCACAGTCTGACAGCAGG-3′;

[0019] S3. Synthesize the double-stranded strand of the target sgRNA: Pipette 10 μL of each synthetic primer of S2 and 80 μL of ddH2O into a centrifuge tube, gently vortex to mix, briefly centrifuge to make all the liquid at the bottom of the centrifuge tube, then heat in a 95°C water bath for 10 minutes and cool naturally. The double-stranded strands formed by annealing the above S2 primers all have "TAGG-" and "AAAC-" sticky ends.

[0020] S4. Preparation of pDR274-sgRNA vector: Use BsaⅠ enzyme to restrictively cut the pDR274 plasmid, use T4 ligase to connect the double-stranded annealed product and the pDR274 plasmid cut by BsaⅠ enzyme, and use the ligation product as a template for PCR amplification. The selected primers are the upstream forward primer 5'-TAGGCCTGCTGTCAGACTGTGG-3' and the downstream reverse primer 5'-GTAAAACGACGGCCAGT-3';

[0021] S5. Preparation of sgRNA in vitro transcription template: pDR274-sgRNA vector was used as template, and primers were used: upstream forward primer 5'-CTCAGGAAACAGCTATGACA-3'; downstream reverse primer 5'

[0022] -TTTAAAAGCACCGACTCGGTGCCAC-3', perform PCR and purify the recovered PCR product as a template for sgRNA in vitro transcription;

[0023] S6. Synthesis of gRNA: The sgRNA in vitro transcription template in step S5 is transcribed in vitro using T7 transcriptase, and purified and recovered to obtain sgRNA;

[0024] S7, microinjection: The gRNA recovered in step S6 and the commercial Cas9 protein were mixed and then microinjected into zebrafish 1-2 cell stage embryos, with 600 embryos injected;

[0025] S8. Target effectiveness detection: 20 zebrafish embryos were collected 24 hours after the injection in step S7, genomic DNA was extracted, and the target sequence containing the target was amplified by PCR and sequenced. The primer used for PCR was the upstream forward primer 5'

[0026] -CAACAGCGTCAGAATCGGTG-3'; downstream reverse primer 5'-GTTGAGGAATTCCCTTGCTCTG-3'; the injected batch embryos whose sequencing results showed chaotic peaks near the target site were placed in the breeding system and raised until sexual maturity, and the obtained individuals were gene knockout positive chimeras F0; the positive F0 individuals were test-crossed with the wild type, and the mutant genotype of the next generation of zebrafish was detected to obtain ace2 mutant zebrafish F1 (+ / -) with an effective mutation; female-male zebrafish mutants with the same effective mutation type were selected for self-pollination to obtain zebrafish homozygous mutant F2 (- / -).

[0027] On the other hand, the present invention also provides the use of the Ace2 gene-deficient zebrafish mutant obtained according to the method for studying the mechanism by which ace2 regulates intestinal function and mediates fish growth.

[0028] On the other hand, the present invention also provides the use of the Ace2 gene-deficient zebrafish mutant obtained according to the method for studying the host genetic-mediated intestinal function and intestinal flora regulation mechanism.

[0029] On the other hand, the present invention also provides the use of the Ace2 gene-deficient zebrafish mutant obtained according to the method for screening drugs and treatment methods for intestinal disorders.

[0030] On the other hand, the present invention also provides the use of the Ace2 gene-deficient zebrafish mutant obtained according to the method for screening intestinal flora that is beneficial to intestinal homeostasis and growth.

[0031] The present invention uses ace2 mutant zebrafish as experimental animals, and the constructed growth inhibition model has significant effects, which can effectively reflect the mechanism by which ace2 regulates intestinal function and thus affects growth and development. In addition, the method of the present invention has low cost, short cycle, good repeatability, and strong reliability, which can effectively reduce the experimental cost, conduct in-depth research on the intestinal function regulated by ace2 and the regulatory mechanism of the flora on growth and development, and is conducive to screening intestinal flora that is beneficial to growth and verification, which helps to understand the development law of ace2 regulating fish growth, and provides a theoretical basis for promoting rapid growth of fish and efficient feed utilization variety breeding. BRIEF DESCRIPTION OF THE DRAWINGS

[0032] Figure 1 This is a schematic diagram of the ace2 gene structure and gene editing site sequence of the wild-type (WT) and ace2 gene homozygous mutant zebrafish (ace2- / -), where the black boxes represent exons, the black underline represents the target sequence designed by sgRNA, the black dash represents the missing bases in the homozygous mutant zebrafish, and the red letters represent the predicted amino acid sequence changes in the homozygous mutant zebrafish.

[0033] Figure 2 This is the result of gene editing efficiency test of F0 generation zebrafish, where lanes 1-10 are ace2 gene-edited zebrafish tail fin samples, lane 11 is the marker, and lanes 12-13 are wild-type zebrafish tail fin samples. The samples marked with red arrows are samples with successful ace2 gene editing.

[0034] Figure 3 This is a comparison chart of the sequencing sequences of the gene editing sites of wild-type zebrafish (WT) and ace2 gene homozygous mutant zebrafish (ace2- / -).

[0035] Figure 4It is a graph showing the results of high resolution melting curve analysis (HRMA) and heteroduplex mobility analysis (HMA) of wild-type zebrafish (WT), heterozygous mutant zebrafish (ace2+ / -) and homozygous mutant zebrafish (ace2- / -).

[0036] Figure 5 This is a schematic diagram comparing the body length and weight of wild-type and homozygous mutant zebrafish at different growth stages. A, D: intuitive comparison of the appearance of wild-type and homozygous mutant zebrafish at 50dpf and 110dpf, B, E: body length statistics of wild-type and homozygous mutant zebrafish at 50dpf and 110dpf, C, F: weight statistics of wild-type and homozygous mutant zebrafish at 50dpf and 110dpf.

[0037] Figure 6 This is a statistical comparison of the results of measuring the amino acid content in plasma of wild-type and homozygous mutant zebrafish at 110 dpf. DETAILED DESCRIPTION

[0038] The present invention will be further described below in conjunction with specific examples. It should be understood that the following examples are only used to illustrate the present invention, rather than to limit the scope of the present invention.

[0039] 1. Analysis of the zebrafish Ace2 gene

[0040] Angiotensin-converting enzyme 2 (Ace2) is a key protease that regulates the renin-angiotensin system. It plays an important role in a variety of biological processes such as nutrient absorption, metabolism, and immunity in mammals, but research on Ace2 in fish is relatively scarce. As an important component of the renin-angiotensin system, Ace2 can convert angiotensin II (ANG II) with vasoconstriction function into angiotensin 1-7 (ANG 1-7) with vasodilator function to regulate blood pressure balance. At the same time, Ace2 is also involved in multiple physiological processes such as cardiac function, lipid metabolism, and inflammatory response. In recent years, Ace2 has attracted much attention in biomedical research because it is a key receptor for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, new coronavirus) to enter cells and plays an important role in the infection and pathological process of COVID-19. In addition to its traditional functions in the renin-angiotensin system, studies in mice have also found that Ace2 plays an important role in intestinal function. Ace2 knockout mice grow slowly, and compared with the control group, Ace2 mutant mice lose 4%-20% of their body weight at different test ages. Further studies have found that the levels of neutral amino acids such as tryptophan in the blood of Ace2-deficient mice are significantly reduced, and multiple amino acid metabolic pathways are impaired, indicating that Ace2 mediates mouse growth by regulating amino acids. Although the role of Ace2 in blood pressure regulation, intestinal amino acid transport, and SARS-CoV-2 invasion mechanism has been widely studied in humans and other mammals, the function of Ace2 in fish is not clear. Although Ace2 has been found in different fish such as tilapia, catfish, salmon, rainbow trout, and zebrafish, there have been no in-depth studies on the function of Ace2 in fish. A preliminary comparison of fish Ace2 protein sequences revealed that the sequence homology of fish Ace2 was high, and it was speculated that the function of Ace2 in fish is relatively conservative. The model constructed in the invention found that the Ace2 deficiency caused a serious weight loss in zebrafish (the weight of the mutant group decreased by 82% and 51% at 50 days and 110 days respectively compared with the control group of the same age), and the amino acid content in the plasma of the mutant group was significantly lower than that of the control group. The ace2 zebrafish knockout model constructed in the present invention can be used as a model of ace2 regulating intestinal amino acid absorption function for various studies, and the research results can be extended to economic fish and human diseases.

[0041] 2. Design of sgRNA for zebrafish ace2 gene

[0042] The information of zebrafish ace2 gene was queried in NCBI (National Center for Biotechnology Information). It was found that zebrafish ace2 gene is a protein-coding gene located on chromosome 11 of zebrafish, and there are 2 reference transcripts. In order to achieve the purpose of knocking out the ace2 gene, the CRISPR / Cas9 technology was used to delete several bases in the target gene site to achieve the effect of disrupting protein synthesis. The target design should be located in the protein coding region (Coding sequence, CDS) of the gene. Therefore, the genome sequence of the chromosomes corresponding to the above two genes and the CDS of the transcripts were downloaded respectively, and each CDS was compared with the corresponding genome sequence in SnapGene. The common comparison area was selected to design sgRNA in the online website https: / / www.crisprscan.org to obtain the knockout target of the ace2 gene.

[0043] The sgRNA target sequence is located on exon 1 of the zebrafish ace2 genome, and the sgRNA target sequence is shown as 5'-GGCCTGCTGTCAGACTGTGG-3'.

[0044] Figure 1 The diagram shows the ace2 gene structure and gene editing site sequence of the wild-type (WT) and ace2 gene homozygous mutant zebrafish (ace2- / -), where the black boxes represent exons, the black underline represents the target sequence designed by sgRNA, the black dash represents the missing base in the homozygous mutant zebrafish, and the red letters represent the predicted amino acid sequence changes in the homozygous mutant zebrafish.

[0045] 3. Preparation of sgRNA in vitro transcription template

[0046] Construction of pDR274-ace2 targeting sgRNA recombinant plasmid:

[0047] ace2 Nucleic acid sequence (5'→3') sgRNA synthesis upstream forward primer Oligo 1 TAGGCCTGCTGTCAGACTGTGG sgRNA synthesis downstream reverse primer Oligo 2 AAACCCACAGTCTGACAGCAGG

[0048] According to the above table, synthesize oligonucleotide chains Oligo 1-2 (10μM), use a pipette to draw 10μL of Oligo 1 and Oligo 2, 80μL of ddH2O into a 1.5mL centrifuge tube, gently vortex to mix, centrifuge briefly to make all the liquid at the bottom of the centrifuge tube, then place the centrifuge tube in a 95℃ water bath for 10 minutes, and cool naturally. The double-stranded chains formed by annealing of the above two have "TAGG-" and "AAAC-" sticky ends.

[0049] The pDR274 plasmid was restricted by BsaⅠ enzyme. The restriction reaction system was as follows:

[0050] BsaⅠ enzyme (10U / μL) 1μL pDR274 plasmid 1 μg 10×NEBuffer 5μL Total volume 50μL Reaction temperature 37℃ Reaction time 60min

[0051] The double-stranded plasmid obtained by annealing was connected with the pDR274 plasmid cut by BsaⅠ enzyme using T4 ligase, and PCR amplification was performed using the ligation product as a template to check whether the ligation reaction was successful.

[0052] Component name volume 2×Accurate Taq Master Mix(dye plus) 12.5μL template 1μL Upstream primer (Oligo1) 1μL Downstream primer (1861_m13) 1μL Nuclease-free water 9.5μL Total volume 25μL

[0053] Note: The sequence of primer 1861_m13 is: 5'-GTAAAACGACGGCCAGT-3'.

[0054] The PCR reaction conditions are as follows:

[0055]

[0056] The recombinant plasmid was transformed into E. coli cells DH5α, and single clones containing the recombinant plasmid were screened by colony PCR method.

[0057] Use EZNAEndo-free Plasmid Mini KitⅡ to extract plasmid. The specific steps are as follows:

[0058] Place ETR Solution, N3 Buffer, and Solution I on ice in advance.

[0059] 1. Inoculate the bacteria into 20 ml of resistance medium at a ratio of 1:100, shake at 37°C and 220 rpm for 12-16 hours, centrifuge at 5000g for 10 minutes at RT, and discard the supernatant.

[0060] 2. Add 500ul Solution I (4℃, pre-added with RNaseA), resuspend by vortexing, and transfer to a 2ml EP tube.

[0061] 3. Add 500ul Solution II, invert 10 times, let the solution clear, and leave at room temperature for 2-5 minutes.

[0062] 4. (To remove genomic DNA) Add 250ul (half volume) N3 Buffer and invert several times until a white precipitate appears.

[0063] 5. Centrifuge at 13000g for 5 min at RT, aspirate the supernatant into a 1.5 ml EP tube, and centrifuge at 13000g for 10 min at RT.

[0064] 6. Carefully transfer the supernatant to a 2 ml EP tube.

[0065] 7. Add 600ul (0.5 times volume) of ethanol, invert 6-7 times to mix, and let stand at room temperature for 1-2 minutes.

[0066] 8. Load 700ul of the sample onto the column each time, centrifuge at high speed for 1min, and discard the filtrate.

[0067] 9. (Deproteinization) Add 500ul HBC Buffer, centrifuge at high speed for 1min, and discard the filtrate.

[0068] 10. Add 700ul DNA wash buffer, centrifuge at high speed for 1min, discard the filtrate, and repeat once.

[0069] 11. Shake at high speed for 2 minutes and place the column into a 1.5 ml EP tube.

[0070] 12. Add 80-100ul dd water and leave at room temperature for 1 minute.

[0071] 13. Centrifuge at high speed for 1 min and aspirate the eluted product.

[0072] High-fidelity DNA polymerase KOD FX was used to amplify the in vitro transcription template. The primers were: upstream forward primer (3111_gRNA) 5'-CTCAGGAAACAGCTATGACA-3'; downstream reverse primer (2134_M13) 5'-TTTAAAAGCACCGACTCGGTGCCAC-3'.

[0073] Component name volume 2x PCR buffer for KOD FX 25μL 2mM dNTPs 10μL Primer 3111_gRNA 1.5μL Primer 2134_M13 1.5μL template About 50ng KOD FX 1μL Autoclaved water Add to 50 μL

[0074] The PCR reaction conditions are as follows:

[0075]

[0076] Cut the target fragment under UV light and use EZNAGel Extraction Kit to recover the fragment. The specific steps are as follows:

[0077] 1. The density of the gel block is assumed to be 1 g / mL and is loaded into a 1.5 mL tube;

[0078] 2. Add 1 volume of Binding Buffer (XP2);

[0079] 3. Incubate at 50-60℃ for 7 minutes until the gel is completely melted. Vortex / shake the tube every 2-3 minutes. After the gel is completely melted, cool the gel to room temperature.

[0080] 4. Insert the HiBind DNA Mini Column into a 2 mL collection tube, add no more than 700 μL of gel to the centrifuge column, centrifuge at 10,000 g for 1 min at room temperature, and discard the filtrate;

[0081] 5. Transfer the remaining sample to the centrifuge column, no more than 700 μL each time;

[0082] 6. Add 300 μL Binding Buffer (XP2), centrifuge at 13000 g for 1 min at room temperature, and discard the filtrate;

[0083] 7. Add 700 μL SPW Wash Buffer, centrifuge at 13000 g for 1 min at room temperature, and discard the filtrate;

[0084] 8. Repeat step 7;

[0085] 9. Spin the centrifugal column for 2 min (room temperature, 13000 g) and evaporate the residual ethanol in a 56°C metal bath;

[0086] 10. Transfer the centrifuge column to a new 1.5 mL tube, add 30-50 μL Elution Buffer or deionized water to the center of the column membrane, and let stand at room temperature for 2 minutes;

[0087] 11. Centrifuge at 13000g for 1 min and aspirate the eluted product.

[0088] The DNA recovered from the gel excision was amplified again using KOD FX enzyme, and the product was recovered using EZNACyclePure Kit. The specific steps are as follows:

[0089] 1. Determine the volume of the PCR reaction system and transfer the sample to a 1.5 mL centrifuge tube;

[0090] 2. Add 4-5 volumes of CP Buffer (for PCR products <200 bp, add 5 volumes of CP Buffer and 0.4 volumes of 100% isopropanol);

[0091] 3. Vortex to mix thoroughly and centrifuge briefly to remove all liquid from the tube.

[0092] 4. Insert the HiBind DNA Mini Column into a 2 mL collection tube, add the sample in step 3 to the centrifuge column, centrifuge at 13000 g for 1 min at room temperature, and discard the filtrate;

[0093] 5. Add 700 μL DNA Wash Buffer, centrifuge at 13000 g for 1 min, and discard the filtrate;

[0094] 6. Repeat step 5;

[0095] 7. Air spin at 13000g for 2 min, and evaporate the residual ethanol in a metal bath at 56℃ for 2 min;

[0096] 8. Transfer the centrifuge column to a new 1.5 mL centrifuge tube and add 30-50 μL Elution Buffer, TE Buffer or sterilized deionized water to the center of the centrifuge column membrane;

[0097] 9. Stand at room temperature for 2 minutes (56℃ metal bath for 2 minutes can accelerate elution, make sure to cover the lid);

[0098] 10. Centrifuge at 13000g for 1 min and re-aspirate to elute.

[0099] The recovered DNA was used as a template for subsequent in vitro transcription experiments.

[0100] 4. Preparation and Purification of sgRNA

[0101] Using MEGAscript T7 TM Transcription Kit was used for in vitro transcription.

[0102] The reaction system is as follows:

[0103] Component name volume ATP solution 2μL CTP solution 2μL GTP solution 2μL UTP Solution 2μL 10× reaction buffer 2μL In vitro transcription template 8μL Enzyme Mix 2μL

[0104] Here are the steps:

[0105] 1. Place RNA Polymerase Enzyme Mix on ice, vortex 10× reaction buffer and ATP, CTP, GTP, UTP four ribonucleotide solutions until completely dissolved, place AGCU on ice after melting, and heat 10× reaction buffer to room temperature. Shake all liquids to the bottom of the tube before using all reagents;

[0106] 2. The total volume of each in vitro transcription system is 20 μL. Sequentially Add 8 μL of ribonucleotides (2 μL each of AGCU, for multiple reactions, premix first and then dispense), 2 μL of 10× reaction buffer, 0.1-0.2 μg of purified PCR product (add 8 μL directly) and 2 μL of Enzyme Mix to a 1.5 mL EP tube without enzyme. Flick the PCR tube or mix it gently with a pipette. Centrifuge briefly to discard all the liquid to the bottom of the tube. Incubate at 37°C for 4-6 hours.

[0107] 3. Add 50 μL LiCl Precipitation Solution to terminate the reaction and precipitate the RNA, vortex to mix, shake all the liquid to the bottom of the tube, and place at -20°C overnight;

[0108] 4. Centrifuge at 12000 rcf and 4°C for 15 min to pellet the RNA;

[0109] 5. Remove the supernatant, add 1 mL of 70% or 75% ethanol to wash the precipitate once, and centrifuge at 12000 rcf and 4°C for 10-15 min to remove unbound nucleotides to the maximum extent;

[0110] 6. Remove the ethanol, air-dry the RNA precipitate (be careful not to let it dry too much), resuspend it in 20-30 μL of nuclease-free water, quickly vortex to mix, and centrifuge briefly to throw all the liquid to the bottom of the tube. After measuring the concentration, store the RNA at -20℃ or -80℃.

[0111] 5. Microinjection and Target Validity Testing

[0112] sgRNA (45ng / μl) and commercial Cas9 protein (New England Biolabs, USA) were co-microinjected into wild-type zebrafish embryos at the 1-cell stage. Genomic DNA was extracted by alkaline lysis, and several injected embryos were selected. 30-50μl NaOH (50nM) solution was added and reacted at 95°C for 10min until the tissue was completely dissolved. After cooling to room temperature, 3-5μl Tris-HCl (pH 8.0) was added to neutralize the reaction system. The reaction system was centrifuged at 12000rpm for 1 minute, and the supernatant was used as a PCR template for genotype identification. The designed primers (upstream forward primer: 5'-CAACAGCGTCAGAATCGGTG-3'; downstream reverse primer: 5'-GTTGAGGAATTCCCTTGCTCTG-3') were used for PCR amplification detection of F0 generation chimeric zebrafish. The PCR reaction system is as follows:

[0113] Genomic DNA template 1μL 2x PCR mix 10μL Upstream forward primer (10 μM) 1μL Downstream reverse primer (10 μM) 1μL <![CDATA[ddH2O]]> Up to 20 μL

[0114] Amplification was performed using a Bio-Rad PCR instrument under the following conditions: 95°C for 3 min, 95°C for 15 s, 60°C for 15 s, and 72°C for 45 s for 40 cycles.

[0115] The other embryos of the same batch that showed chaotic peaks near the melting curve were raised to sexual maturity and used as parents to breed the next generation; the next generation embryos were screened again by the above PCR and sequencing methods to detect effective mutant type zebrafish, thereby obtaining ace2 gene mutant zebrafish. Positive individuals were screened and cross-crossed with wild-type zebrafish to produce heterozygous mutations (+ / -), and the mutation type was determined by sequencing. Heterozygous zebrafish (+ / -) with the same promoter fragment deletion mutation type were selected for self-crossing to produce homozygous offspring (- / -).

[0116] Figure 2The results of gene editing efficiency detection of F0 generation zebrafish are shown, where lanes 1-10 are ace2 gene-edited zebrafish tail fin samples, lane 11 is a marker, and lanes 12-13 are wild-type zebrafish tail fin samples. The samples marked with red arrows are samples with successful ace2 gene editing.

[0117] Figure 3 The sequencing sequence comparison results of the gene editing sites of wild-type zebrafish (WT) and ace2 gene homozygous mutant zebrafish (ace2- / -) are shown.

[0118] 6. Genotyping of mutants and wild-types

[0119] The above alkaline lysis method was used to cut the tail fin of the adult fish to extract genomic DNA. The zebrafish tail fin samples were amplified by PCR using primers (upstream primer: CAACAGCGTCAGAATCGGTG; downstream primer: GTTGAGGAATTCCCTTGCTCTG). High Resolution Melting Analysis (HRMA) was used to identify the genotype of genomic DNA: primers targeting the mutation site were designed (upstream forward primer: CAACAGCGTCAGAATCGGTG; downstream reverse primer: GTTGAGGAATTCCCTTGCTCTG), and the PCR reaction system was as follows:

[0120] Genomic DNA template 1μL 2x PCR mix 10μL Upstream forward primer (10 μM) 1μL Downstream reverse primer (10 μM) 1μL <![CDATA[ddH2O]]> Up to 20 μL

[0121] Amplification reaction was performed using a Bio-Rad PCR instrument with the following conditions: 95°C for 3 min, 95°C for 15 s, 60°C for 15 s, and 72°C for 45 s for 40 cycles.

[0122] Different mutation types were distinguished based on the differences in melting curves of wild type, heterozygous mutation, and homozygous mutation in fluorescence quantitative PCR reactions. For genotypes that were difficult to distinguish using HMRA, PCR products were run on non-denaturing PAGE gel electrophoresis and heteroduplex mobility analysis (HMA) was performed to further distinguish them based on the bands.

[0123] Figure 4High-resolution melting curve analysis (left figure) and heteroduplex mobility analysis detection results (right figure) of wild-type zebrafish (WT), heterozygous mutant zebrafish (ace2+ / -) and homozygous mutant zebrafish (ace2- / -) are shown. As shown in the figure, in the high-resolution melting curve analysis diagram (left figure), the red, blue and black curves are the melting curves of homozygous mutant, heterozygous mutant and wild-type zebrafish, respectively, and the peaks of the three melting curves are different, that is, the zebrafish of the three genotypes (wild type, heterozygous mutant and homozygous mutant) can be effectively distinguished; in the agarose gel electrophoresis diagram (right figure), from left to right are the bands of wild-type, homozygous mutant and heterozygous mutant zebrafish, and the bands of the three genotypes of zebrafish are different, that is, the zebrafish of the three genotypes can be effectively distinguished.

[0124] 7. Zebrafish Model Phenotypic Analysis

[0125] Zebrafish growth trait parameters: 50-day-old and 110-day-old fish were selected and anesthetized with an appropriate amount of tricaine solution (MS-222, Sigma-Aldrich, USA). Each individual in the three groups of Ace2 mutant strains, overexpression strains and control groups was weighed (mg) and measured for standard length (cm), and photos were taken for record. During the 110-day experiment, the experimental fish were fed by hand three times a day until they were obviously full. By comparing the differences in basic growth trait parameters between the zebrafish Ace2 mutant strain and the control group, the function of Ace2 in fish growth was clarified.

[0126] Figure 5 The figure shows the body length and weight comparison of wild-type and homozygous mutant zebrafish at different growth stages (Con: wild-type; Mut: homozygous mutant of ace2 gene (ace2- / -)). Among them, A, D: visual comparison of the appearance of wild-type and homozygous mutant zebrafish at 50dpf and 110dpf; B, E: statistical graphs of body length of wild-type and homozygous mutant zebrafish at 50dpf and 110dpf; C, F: statistical graphs of weight of wild-type and homozygous mutant zebrafish at 50dpf and 110dpf. Figure 5 As shown, at 50 dpf, the body length and weight of the homozygous mutant zebrafish were significantly lower than those of the wild-type zebrafish, and the body weight was 82% lower than that of the wild-type; at 110 dpf, the body length and weight of the homozygous mutant zebrafish were significantly lower than those of the wild-type zebrafish, and the body weight was 51% lower than that of the wild-type.

[0127] Determination of amino acid content in plasma: Fish were anesthetized with an appropriate amount of tricaine solution (MS-222, Sigma-Aldrich, USA). After complete anesthesia, blood samples of fish were collected from the heart using glass capillaries and transferred to EP tubes rinsed with sodium heparin. The supernatant was collected after centrifugation (3000 rpm, 30 min, 4 ° C), and the protein concentration was quantified using 2d Quant Kit (GE Healthcare, Piscataway, NJ). The total amino acid (T-AA) assay kit (Nanjing Jiancheng Company) was used to determine the content of amino acids in plasma samples.

[0128] Figure 6 The figure shows the statistical comparison of the results of the determination of the amino acid content in the plasma of wild-type and homozygous mutant zebrafish at 110 dpf (Con: wild-type; Mut: homozygous mutant of ace2 gene (ace2- / -)). Figure 6 As shown, compared with wild-type zebrafish, the amino acid content in the plasma of homozygous mutant zebrafish was significantly reduced.

[0129] As can be seen from the above results, the present invention uses ace2 mutant zebrafish as experimental animals, and the constructed growth inhibition model has significant effects, which can effectively reflect the mechanism by which ace2 regulates intestinal function and affects growth and development. In addition, the method of the present invention has low cost, short cycle, good repeatability, and strong reliability, which can effectively reduce the experimental cost, and deeply study the intestinal function regulated by ace2 and the regulatory mechanism of the flora on growth and development, which is conducive to screening the intestinal flora that is beneficial to growth, and verifying it, which helps to understand the development law of ace2 regulating fish growth, and provides a theoretical basis for promoting rapid growth of fish and efficient utilization of feed. The Ace2 gene-deficient zebrafish mutant obtained according to the method of the present invention can be used to study the mechanism of ace2 regulating intestinal function to mediate fish growth, study the intestinal function and intestinal flora regulatory mechanism mediated by host genetics, screen drugs and treatment methods for treating intestinal disorders, and screen intestinal flora that are beneficial to intestinal homeostasis and growth.

Claims

1. A method for preparing an Ace2 gene-deficient zebrafish mutant, comprising the following steps: After mixing the artificial in vitro transcribed sgRNA fragment and the Cas9 protein, the mixture is injected into the zebrafish fertilized eggs at the 1-2 cell stage by microinjection. The fertilized eggs are hatched and cultured to obtain the Ace2 gene-deficient zebrafish mutant.

2. The method according to claim 1, characterized in that Using CRISPR / Cas9 technology, sgRNA was designed for exon 1 of the zebrafish ace2 genome.

3. The method according to claim 2, characterized in that The sgRNA target sequence is located on exon 1 of the zebrafish ace2 genome, and the sgRNA target sequence is 5'-GGCCTGCTGTCAGACTGTGG-3'.

4. The method according to claim 3, characterized in that The PCR primer pairs for sgRNA are as follows: Upstream forward primer sequence: 5′-CAACAGCGTCAGAATCGGTG-3′; Downstream reverse primer sequence: 5′-GTTGAGGAATTCCCTTGCTCTG-3′.

5. The method according to claim 1, characterized in that The vector used to express sgRNA was pDR274-sgRNA vector.

6. The method according to claim 1, characterized in that The specific steps of the method are as follows: S1, the gRNA target sequence was designed on exon 1 of the zebrafish ace2 genome, and the sgRNA target sequence was 5'-GGCCTGCTGTCAGACTGTGG-3'; S2, synthetic primers: sgRNA synthesis upstream forward primer: 5′-TAGGCCTGCTGTCAGACTGTGG-3′; sgRNA synthesis downstream reverse primer: 5′-AAACCCACAGTCTGACAGCAGG-3′; S3. Synthesize the double-stranded strand of the target sgRNA: Pipette 10 μL of each synthetic primer of S2 and 80 μL of ddH2O into a centrifuge tube, gently vortex to mix, briefly centrifuge to make all the liquid at the bottom of the centrifuge tube, then heat in a 95°C water bath for 10 minutes and cool naturally. The double-stranded strands formed by annealing the above S2 primers all have "tagg-" and "aaac-" sticky ends. S4. Preparation of pDR274-sgRNA vector: Use BsaⅠ enzyme to restrictively cut the pDR274 plasmid, use T4 ligase to connect the double-stranded annealed product and the pDR274 plasmid cut by BsaⅠ enzyme, and use the ligation product as a template for PCR amplification. The selected primers are: upstream forward primer 5'-TAGGCCTGCTGTCAGACTGTGG-3'; downstream reverse primer 5'-GTAAAACGACGGCCAGT-3'; S5. Prepare sgRNA in vitro transcription template: Use pDR274-sgRNA vector as template and primers: upstream forward primer 5'-CTCAGGAAACAGCTATGACA-3'; downstream reverse primer 5'-TTTAAAAGCACCGACTCGGTGCCAC-3', perform PCR and purify and recover the PCR product as sgRNA in vitro transcription template; S6. Synthesis of gRNA: The sgRNA in vitro transcription template in step S5 is transcribed in vitro using T7 transcriptase, and purified and recovered to obtain sgRNA; S7, microinjection: The gRNA recovered in step S6 and the commercial Cas9 protein were mixed and then microinjected into zebrafish 1-2 cell stage embryos, with 600 embryos injected; S8. Target effectiveness detection: 20 zebrafish embryos were collected 24 hours after the injection in step S7, and genomic DNA was extracted. The target sequence containing the target was amplified by PCR and sequenced. The primers used for PCR were the upstream forward primer 5'-CAACAGCGTCAGAATCGGTG-3'; the downstream reverse primer 5'-GTTGAGGAATTCCCTTGCTCTG-3'; the injected batch embryos whose sequencing results showed chaotic peaks near the target were put into the breeding system and raised until sexual maturity, and the obtained individuals were gene knockout positive chimeras F0; the positive F0 individuals were test-crossed with the wild type, and the mutant genotype of the next generation of zebrafish was detected to obtain ace2 mutant zebrafish F1 (+ / -) with an effective mutation; female and male zebrafish mutants with the same effective mutation type were selected for self-pollination to obtain zebrafish homozygous mutants F2 (- / -).

7. Application of the Ace2 gene-deficient zebrafish mutant obtained by the method according to any one of claims 1 to 6 in studying the mechanism by which ace2 regulates intestinal function and mediates fish growth.

8. Use of the Ace2 gene-deficient zebrafish mutant obtained by the method according to any one of claims 1 to 6 for studying host genetic-mediated intestinal function and intestinal flora regulation mechanisms.

9. Use of the Ace2 gene-deficient zebrafish mutant obtained by the method according to any one of claims 1 to 6 for screening drugs and treatment methods for treating intestinal disorders.

10. Use of the Ace2 gene-deficient zebrafish mutant obtained by the method according to any one of claims 1 to 6 for screening intestinal flora that is beneficial to intestinal homeostasis and growth.